STOCK TITAN

[Form 4] Arvinas, Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Insider Trading Activity Report: Leslie V. Norwalk, Director of Arvinas (NASDAQ: ARVN), received significant equity compensation on June 25, 2025. The transaction includes:

  • Restricted Stock Units (RSUs): Granted 16,025 RSUs that convert to common stock at no cost, vesting on June 25, 2026 or at the first board meeting after the next annual stockholder meeting
  • Stock Options: Awarded 23,105 options with exercise price of $7.80, expiring June 24, 2035, following the same vesting schedule as RSUs

Following these transactions, Norwalk directly owns 26,045 shares of common stock and 23,105 stock options. The equity grants appear to be part of the company's director compensation program, with both RSUs and options structured with one-year cliff vesting, subject to continued service.

Rapporto sulle Operazioni di Insider Trading: Leslie V. Norwalk, Direttore di Arvinas (NASDAQ: ARVN), ha ricevuto una significativa compensazione azionaria il 25 giugno 2025. La transazione comprende:

  • Restricted Stock Units (RSU): Concessi 16.025 RSU che si convertiranno in azioni ordinarie senza costi, con maturazione prevista per il 25 giugno 2026 o alla prima riunione del consiglio dopo l’assemblea annuale degli azionisti.
  • Opzioni su Azioni: Assegnate 23.105 opzioni con prezzo di esercizio di 7,80$, con scadenza il 24 giugno 2035, seguendo lo stesso piano di maturazione delle RSU.

Dopo queste operazioni, Norwalk detiene direttamente 26.045 azioni ordinarie e 23.105 opzioni su azioni. Le assegnazioni azionarie sembrano far parte del programma di compensazione per i direttori della società, con entrambe le RSU e le opzioni strutturate con un vesting a cliff di un anno, subordinato al mantenimento del servizio.

Informe de Actividad de Operaciones con Información Privilegiada: Leslie V. Norwalk, Director de Arvinas (NASDAQ: ARVN), recibió una compensación significativa en acciones el 25 de junio de 2025. La transacción incluye:

  • Unidades de Acciones Restringidas (RSU): Se otorgaron 16,025 RSU que se convierten en acciones ordinarias sin costo, con vencimiento el 25 de junio de 2026 o en la primera reunión del consejo posterior a la próxima junta anual de accionistas.
  • Opciones sobre Acciones: Se concedieron 23,105 opciones con un precio de ejercicio de $7.80, que expiran el 24 de junio de 2035, siguiendo el mismo calendario de adquisición que las RSU.

Después de estas transacciones, Norwalk posee directamente 26,045 acciones ordinarias y 23,105 opciones sobre acciones. Las concesiones de capital parecen formar parte del programa de compensación para directores de la compañía, con RSU y opciones estructuradas con un vesting tipo cliff de un año, sujeto a la continuidad del servicio.

내부자 거래 활동 보고서: Arvinas (NASDAQ: ARVN) 이사인 Leslie V. Norwalk는 2025년 6월 25일에 상당한 주식 보상을 받았습니다. 거래 내역은 다음과 같습니다:

  • 제한 주식 단위(RSUs): 16,025 RSU가 부여되었으며, 비용 없이 보통주로 전환되며, 2026년 6월 25일 또는 다음 연례 주주총회 이후 첫 이사회 회의 시점에 권리가 확정됩니다.
  • 스톡 옵션: 행사가격 $7.80의 23,105 옵션이 부여되었으며, 만료일은 2035년 6월 24일이고, RSU와 동일한 권리확정 일정이 적용됩니다.

이 거래 이후 Norwalk는 직접적으로 26,045주의 보통주와 23,105주의 스톡 옵션을 보유하게 됩니다. 이 주식 보상은 회사의 이사 보상 프로그램의 일부로 보이며, RSU와 옵션 모두 1년 클리프 베스팅으로 구성되어 있으며, 계속 근무가 조건입니다.

Rapport d'Activité d'Opérations d'Initiés : Leslie V. Norwalk, administrateur d'Arvinas (NASDAQ : ARVN), a reçu une importante compensation en actions le 25 juin 2025. La transaction comprend :

  • Unités d’Actions Restreintes (RSU) : Attribution de 16 025 RSU convertibles en actions ordinaires sans frais, acquises le 25 juin 2026 ou lors de la première réunion du conseil suivant la prochaine assemblée annuelle des actionnaires.
  • Options d’Achat d’Actions : Attribution de 23 105 options au prix d’exercice de 7,80 $, expirant le 24 juin 2035, suivant le même calendrier d’acquisition que les RSU.

Suite à ces opérations, Norwalk détient directement 26 045 actions ordinaires et 23 105 options d’achat. Ces attributions font vraisemblablement partie du programme de rémunération des administrateurs de la société, avec un vesting cliff d’un an pour les RSU et options, conditionné à la poursuite du service.

Insider-Handelsaktivitätsbericht: Leslie V. Norwalk, Direktor von Arvinas (NASDAQ: ARVN), erhielt am 25. Juni 2025 eine bedeutende Aktienvergütung. Die Transaktion umfasst:

  • Restricted Stock Units (RSUs): Gewährt wurden 16.025 RSUs, die ohne Kosten in Stammaktien umgewandelt werden, mit einer Vesting-Frist bis zum 25. Juni 2026 oder bis zur ersten Vorstandssitzung nach der nächsten jährlichen Hauptversammlung.
  • Aktienoptionen: Verliehen wurden 23.105 Optionen mit einem Ausübungspreis von 7,80 $, die am 24. Juni 2035 verfallen, mit dem gleichen Vesting-Zeitplan wie die RSUs.

Nach diesen Transaktionen hält Norwalk direkt 26.045 Stammaktien und 23.105 Aktienoptionen. Die Aktienzuteilungen scheinen Teil des Vergütungsprogramms für Direktoren des Unternehmens zu sein, wobei sowohl RSUs als auch Optionen mit einem einjährigen Cliff-Vesting versehen sind, das an die fortgesetzte Tätigkeit gebunden ist.

Positive
  • None.
Negative
  • None.

Rapporto sulle Operazioni di Insider Trading: Leslie V. Norwalk, Direttore di Arvinas (NASDAQ: ARVN), ha ricevuto una significativa compensazione azionaria il 25 giugno 2025. La transazione comprende:

  • Restricted Stock Units (RSU): Concessi 16.025 RSU che si convertiranno in azioni ordinarie senza costi, con maturazione prevista per il 25 giugno 2026 o alla prima riunione del consiglio dopo l’assemblea annuale degli azionisti.
  • Opzioni su Azioni: Assegnate 23.105 opzioni con prezzo di esercizio di 7,80$, con scadenza il 24 giugno 2035, seguendo lo stesso piano di maturazione delle RSU.

Dopo queste operazioni, Norwalk detiene direttamente 26.045 azioni ordinarie e 23.105 opzioni su azioni. Le assegnazioni azionarie sembrano far parte del programma di compensazione per i direttori della società, con entrambe le RSU e le opzioni strutturate con un vesting a cliff di un anno, subordinato al mantenimento del servizio.

Informe de Actividad de Operaciones con Información Privilegiada: Leslie V. Norwalk, Director de Arvinas (NASDAQ: ARVN), recibió una compensación significativa en acciones el 25 de junio de 2025. La transacción incluye:

  • Unidades de Acciones Restringidas (RSU): Se otorgaron 16,025 RSU que se convierten en acciones ordinarias sin costo, con vencimiento el 25 de junio de 2026 o en la primera reunión del consejo posterior a la próxima junta anual de accionistas.
  • Opciones sobre Acciones: Se concedieron 23,105 opciones con un precio de ejercicio de $7.80, que expiran el 24 de junio de 2035, siguiendo el mismo calendario de adquisición que las RSU.

Después de estas transacciones, Norwalk posee directamente 26,045 acciones ordinarias y 23,105 opciones sobre acciones. Las concesiones de capital parecen formar parte del programa de compensación para directores de la compañía, con RSU y opciones estructuradas con un vesting tipo cliff de un año, sujeto a la continuidad del servicio.

내부자 거래 활동 보고서: Arvinas (NASDAQ: ARVN) 이사인 Leslie V. Norwalk는 2025년 6월 25일에 상당한 주식 보상을 받았습니다. 거래 내역은 다음과 같습니다:

  • 제한 주식 단위(RSUs): 16,025 RSU가 부여되었으며, 비용 없이 보통주로 전환되며, 2026년 6월 25일 또는 다음 연례 주주총회 이후 첫 이사회 회의 시점에 권리가 확정됩니다.
  • 스톡 옵션: 행사가격 $7.80의 23,105 옵션이 부여되었으며, 만료일은 2035년 6월 24일이고, RSU와 동일한 권리확정 일정이 적용됩니다.

이 거래 이후 Norwalk는 직접적으로 26,045주의 보통주와 23,105주의 스톡 옵션을 보유하게 됩니다. 이 주식 보상은 회사의 이사 보상 프로그램의 일부로 보이며, RSU와 옵션 모두 1년 클리프 베스팅으로 구성되어 있으며, 계속 근무가 조건입니다.

Rapport d'Activité d'Opérations d'Initiés : Leslie V. Norwalk, administrateur d'Arvinas (NASDAQ : ARVN), a reçu une importante compensation en actions le 25 juin 2025. La transaction comprend :

  • Unités d’Actions Restreintes (RSU) : Attribution de 16 025 RSU convertibles en actions ordinaires sans frais, acquises le 25 juin 2026 ou lors de la première réunion du conseil suivant la prochaine assemblée annuelle des actionnaires.
  • Options d’Achat d’Actions : Attribution de 23 105 options au prix d’exercice de 7,80 $, expirant le 24 juin 2035, suivant le même calendrier d’acquisition que les RSU.

Suite à ces opérations, Norwalk détient directement 26 045 actions ordinaires et 23 105 options d’achat. Ces attributions font vraisemblablement partie du programme de rémunération des administrateurs de la société, avec un vesting cliff d’un an pour les RSU et options, conditionné à la poursuite du service.

Insider-Handelsaktivitätsbericht: Leslie V. Norwalk, Direktor von Arvinas (NASDAQ: ARVN), erhielt am 25. Juni 2025 eine bedeutende Aktienvergütung. Die Transaktion umfasst:

  • Restricted Stock Units (RSUs): Gewährt wurden 16.025 RSUs, die ohne Kosten in Stammaktien umgewandelt werden, mit einer Vesting-Frist bis zum 25. Juni 2026 oder bis zur ersten Vorstandssitzung nach der nächsten jährlichen Hauptversammlung.
  • Aktienoptionen: Verliehen wurden 23.105 Optionen mit einem Ausübungspreis von 7,80 $, die am 24. Juni 2035 verfallen, mit dem gleichen Vesting-Zeitplan wie die RSUs.

Nach diesen Transaktionen hält Norwalk direkt 26.045 Stammaktien und 23.105 Aktienoptionen. Die Aktienzuteilungen scheinen Teil des Vergütungsprogramms für Direktoren des Unternehmens zu sein, wobei sowohl RSUs als auch Optionen mit einem einjährigen Cliff-Vesting versehen sind, das an die fortgesetzte Tätigkeit gebunden ist.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Norwalk Leslie V

(Last) (First) (Middle)
C/O ARVINAS, INC.
5 SCIENCE PARK, 395 WINCHESTER AVE.

(Street)
NEW HAVEN CT 06511

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ARVINAS, INC. [ ARVN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/25/2025 A 16,025(1) A $0 26,045 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $7.8 06/25/2025 A 23,105 (2) 06/24/2035 Common Stock 23,105 $0 23,105 D
Explanation of Responses:
1. The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.
2. This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.
Remarks:
/s/ Jared Freedberg, as attorney-in-fact for Leslie Norwalk 06/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What stock compensation did Leslie Norwalk receive from ARVN on June 25, 2025?

Leslie Norwalk received two forms of stock compensation from Arvinas (ARVN) on June 25, 2025: (1) 16,025 restricted stock units (RSUs) that vest in full on June 25, 2026 or the first board meeting after the next annual stockholder meeting, and (2) stock options to purchase 23,105 shares at an exercise price of $7.80 per share, with the same vesting schedule.

How many ARVN shares does Leslie Norwalk own after the June 2025 grant?

Following the reported transaction, Leslie Norwalk directly owns 26,045 shares of ARVN common stock, plus 23,105 stock options and 16,025 unvested RSUs.

What is the vesting schedule for ARVN's June 2025 director stock grants?

Both the RSUs and stock options granted to director Leslie Norwalk vest in full on the earlier of: (1) June 25, 2026 or (2) the first board meeting held after the next annual stockholder meeting, subject to continued service with Arvinas.

What is the exercise price and expiration date of ARVN stock options granted to Norwalk?

The stock options were granted with an exercise price of $7.80 per share and expire on June 24, 2035, ten years from the grant date.

Who filed this Form 4 for ARVN and when was it filed?

The Form 4 was filed on June 27, 2025 by Jared Freedberg as attorney-in-fact for Leslie Norwalk, who serves as a Director of Arvinas, Inc.
Arvinas

NASDAQ:ARVN

ARVN Rankings

ARVN Latest News

ARVN Latest SEC Filings

ARVN Stock Data

540.14M
68.01M
7.62%
110.32%
18.47%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN